Table 1 Clinical and laboratory data of the ALL patients studied
Variables | ALL patients [N = 96] |
|---|---|
Clinical data | |
Age [years (mean ± SD)] | 6.95 ± 3.01 |
Sex | |
Male [N (%)] | 69 (71.9%) |
Female [N (%)] | 27 (28.1%) |
Pallor [N (%)] | 32 (33.3%) |
Dyspnea [N (%)] | 15 (15.6%) |
Fever [N (%)] | 49 (51%) |
Bleeding [N (%)] | 1 (1.04%) |
Bony pains [N (%)] | 4 (4.1%) |
Lymphadenopathy [N (%)] | 3 (3.1%) |
CNS infiltration [N (%)] | 1 (1.04%) |
Laboratory data | |
WBCs at initial diagnosis [× 109/L (mean ± SD)] | 106.07 ± 128.65 |
Blast count at initial diagnosis [% (mean ± SD)] | 68.4 ± 22.7 |
Hemoglobin at initial diagnosis [g/dL (mean ± SD)] | 7.9 ± 1.791 |
Platelets at initial diagnosis [× 109/L (mean ± SD)] | 44.46 ± 29.19 |
FAB classification | |
L1 [N (%)] | 43 (44.8%) |
L2 [N (%)] | 53 (55.2%) |
Immune-phenotyping | |
B-ALL | |
Pre-B-ALL [N (%)] | 42 (42.7%) |
Common B-ALL [N (%)] | 20 (20.8%) |
T-ALL | |
Early T-ALL [N (%)] | 7 (7.3%) |
Intermediate T-ALL [N (%)] | 25 (26%) |
Late T-ALL [N (%)] | 3 (3.1%) |
Cytogenetic | |
t(1;19) [N (%)] | 3 (3.1%) |
t(4;11) [N (%)] | 0% |
t(12;21) [N (%)] | 0% |
t(9;22), p190 kD [N (%)] | 0% |
t(9;22), p210 kD [N (%)] | 0% |